Notable Analyst Rating Changes 05/24: (PPG) (WPI) (DUK) Upgraded; (BHI) (HGSI) (COG) Downgraded

May 24, 2012 11:25 AM EDT
UPGRADES
BofA/Merrill Lynch upgrades PPG Industries (NYSE: PPG) from Neutral to Buy.

Wells Fargo boosts Watson Pharmaceuticals (NYSE: WPI) from Market Perform to Outperform, raising its price target range from $75 - $79 to $84 - $90. Click Here for more color.

UBS lifts Duke Energy (NYSE: DUK) from Neutral to Buy.

BMO Capital raises Ivanhoe Mines (NYSE: IVN) from Market Perform to Outperform.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Societe Generale downgrades Baker Hughes (NYSE: BHI) from Buy to Hold with a price target of $47.

BMO Capital trims Human Genome Sciences (Nasdaq: HGSI) from Outperform to Market Perform and a price target of $13.

CapitalOne lops Cabot Oil & Gas (NYSE: COG) from Add to Neutral with a price target of $40.

Goldman Sachs reduces General Dynamics Corp. (NYSE: GD) from Neutral to Sell, price target cut from $68 to $56. Click Here for more color.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Macquarie starts Discovery Communications (Nasdaq: DISCA) with a Neutral.

Credit Suisse assumes OCZ Technology Group (Nasdaq: OCZ) with an Outperform and $8 price target.

Stephens begins Cree (Nasdaq: CREE) with an Equal Weight and $35 price target.

Roth Capital starts Nektar Therapeutics (Nasdaq: NKTR) with a Buy and price target of $10.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Credit Suisse, UBS, BMO Capital, Roth Capital, Notable Analyst Rating Changes, Wells Fargo